Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

First Guidance on Deprescribing Stimulants in Adult ADHD

The first-ever deprescribing consensus guidance for adult ADHD stimulants has been published alongside the largest dose-effect analysis of the drugs to date.

For Farmers, Mental Health Care That Fits

Two recently launched initiatives endorse ‘farm-informed therapy’ to support mental health in the prairie provinces.

Is Venetoclax Retreatment Effective in Relapsed CLL?

Researchers review available clinical evidence for retreatment with venetoclax, alone or in combination, in patients with relapsed chronic lymphocytic leukemia.

Prenatal Vitamin D Linked to Modest Gains in Child Memory

High-dose vitamin D3 supplementation during pregnancy may improve memory in children.

Genetic Testing for Kidney Disease Often Not Discussed

A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet established clinical criteria.

Docs Say Patients Are Losing Trust in Their Advice: Survey

In a new Medscape survey of 400 US physicians, nearly half said their patients have less trust in their treatment recommendations. See the key findings from the survey.

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Latest News

The first-ever deprescribing consensus guidance for adult ADHD stimulants has been published alongside the largest dose-effect analysis of the drugs to date.

Two recently launched initiatives endorse ‘farm-informed therapy’ to support mental health in the prairie provinces.

Researchers review available clinical evidence for retreatment with venetoclax, alone or in combination, in patients with relapsed chronic lymphocytic leukemia.

High-dose vitamin D3 supplementation during pregnancy may improve memory in children.

A survey found that clinicians are not discussing genetic testing with 80% of patients with kidney disease who meet established clinical criteria.

In a new Medscape survey of 400 US physicians, nearly half said their patients have less trust in their treatment recommendations. See the key findings from the survey.

News All Time

What a PA Retirement Wave May Mean for Healthcare Access

As more PAs consider retirement, some areas of the country may face shortages, resulting in worse access to healthcare.

PCP Points: GLP-1s and Nutrient Immunity Absorption

Getting needed nutrients from healthy food is best, but supplements can play a role.

Reshaping Pancreatic Cancer Treatment: Inside KRAS

Two KRAS-targeted strategies are starting to reshape treatment for metastatic pancreatic cancer after decades of limited progress with chemotherapy.

Italy's Arbovirus Threat: Is Europe at Greater Risk?

Experts say arboviral outbreaks are becoming a growing public health concern in Europe because of expanding mosquito activity and climate shifts.

How Should You Respond to a Patient Who’s Been Misled?

Pierre de Brémond d’Ars, a French GP who leads the evidence-based medicine group NoFakeMed, tells Medscape’s French edition how to approach patients influenced by false health claims.

A New Era for Locally Advanced NSCLC

Dr Mark Kris explores a radical shift in locally advanced lung cancer: moving away from binary ‘resectable’ labels toward universal induction therapy.

Managing Mental Health After a Prostate Cancer Diagnosis

Beyond the physical, a prostate cancer diagnosis carries significant emotional weight. Understanding this spectrum of challenges is key to supporting the whole patient.

NICE Backs New Targeted Therapy for Advanced Cervical Cancer

NICE has recommended a new treatment option for adults with recurrent or metastatic cervical cancer that has progressed on or after systemic therapy.

Rural GI Workforce Stable in the US, but Concerns Exist

The total number of gastroenterologists increased in the US from 2014 to 2025, but the proportion practicing in rural areas stayed at about 7.5%.

Healthcare Workers Face Mental Health Strain, but Care Lags

Healthcare workers are more likely than non-healthcare workers to report a diagnosis of anxiety and depression, but these conditions often remain untreated.

Comorbidities Linked to Greater Spinal Progression in AS

Higher comorbidity burden, uveitis, and psoriasis are independently associated with accelerated spinal radiographic progression in patients with ankylosing spondylitis.

Robotic Wearable Helps Children With SMA Stand Independently

A lightweight robotic knee device improves strength, muscle growth, and standing ability in children with SMA, with benefits persisting after therapy ended.

Transferrin Receptor Shows Promise as Iron Marker in IBD

Soluble transferrin receptor may predict iron deficiency in patients with non anaemic ulcerative colitis; in patients with Crohn's disease, it is most useful for distinguishing those with anaemia.

P-CABs Do Not Increase Risk for C difficile Infection

The use of potassium-competitive acid blockers is not linked to an increased risk for C difficile infection compared with the use of other acid-suppressive agents.

Spain’s Reliance on Foreign Doctors: Is It Sustainable?

Spain increasingly depends on foreign -trained physicians to fill workforce gaps, raising concerns about accreditation, training standards, and working conditions.

'Swap to Stop' Vape Scheme Aids Smoking Cessation in England

An early evaluation of 'Swap to Stop' scheme in England shows a 4-week quit rate of 34.3% among recipients of free e-cigarette starter kits, with an estimated product cost per 4-week quit of £113.17.

Recommended News For You

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Is Vitamin D a Key to Better Breast Cancer Survival?

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

Why are so many young adults getting cancer?

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

A prostate cancer risk prediction algorithm could help target men at highest risk

Recommended Articles For You

Respiratory Ramifications of Systemic Disease: A Comprehensive Review 

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure  

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025 

Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung cancer screening adherence rates decline annually after baseline screening

2.

MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA

3.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

4.

World's premier cancer institute faces crippling cuts and chaos

5.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

1.

The Power of Romiplostim in Treating Low Platelet Counts 

2.

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies

3.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

4.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

5.

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

5.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot